Login / Signup
Valerie Zgonc
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 4
Top Topics
Stem Cells
Advanced Non Small Cell Lung Cancer
Tyrosine Kinase
Epidermal Growth Factor Receptor
Top Venues
Cancer research communications
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Nitin Roper
,
Rajaa El Meskini
,
Tapan Maity
,
Devon A Atkinson
,
Amanda Day
,
Nathan M Pate
,
Constance M Cultraro
,
Svetlana D Pack
,
Valerie Zgonc
,
Zoe Weaver Ohler
,
Udayan Guha
Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung Cancer.
Cancer research communications
4 (2) (2024)
Nitin Roper
,
Rajaa El Meskini
,
Tapan Maity
,
Devon A Atkinson
,
Amanda Day
,
Nathan M Pate
,
Constance M Cultraro
,
Svetlana D Pack
,
Valerie Zgonc
,
Zoe Weaver Ohler
,
Udayan Guha
Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib Resistant EGFR-Driven Lung Cancer.
Cancer research communications
(2024)
Nitin Roper
,
Rajaa El Meskini
,
Tapan Maity
,
Devon A Atkinson
,
Amanda Day
,
Nathan M Pate
,
Constance M Cultraro
,
Svetlana D Pack
,
Valerie Zgonc
,
Zoe Weaver Ohler
,
Udayan Guha
Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung Cancer.
Cancer research communications
4 (2) (2024)
Nitin Roper
,
Rajaa El Meskini
,
Tapan Maity
,
Devon A Atkinson
,
Amanda Day
,
Nathan M Pate
,
Constance M Cultraro
,
Svetlana D Pack
,
Valerie Zgonc
,
Zoe Weaver Ohler
,
Udayan Guha
Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung Cancer.
Cancer research communications
4 (2) (2024)